EVOMELA vs TEMODAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 13, 2026·How we rate

Possible drug interaction. EVOMELA and TEMODAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EVOMELA	TEMODAR
Rating	New	70/100
Pharmacy pays	—	~$206.51 /30
Type	RX	RX
Active ingredient	MELPHALAN HYDROCHLORIDE	TEMOZOLOMIDE
Manufacturer	Acrotech Biopharma	Merck Sharp Dohme
Dosage forms	Injectable	Capsule, Injectable
Drug class	Alkylating Drug	Alkylating Drug
Boxed warning	Boxed warning	None
Treats	Breast Neoplasms, Multiple Myeloma, Neuroblastoma	Glioblastoma, Melanoma

evomela temodar

Rating

New

70/100

Pharmacy pays

—

~$206.51 /30

Type

Active ingredient

MELPHALAN HYDROCHLORIDE

TEMOZOLOMIDE

Manufacturer

Acrotech Biopharma

Merck Sharp Dohme

Dosage forms

Injectable

Capsule, Injectable

Drug class

Alkylating Drug

Boxed warning

None

Treats

Breast Neoplasms, Multiple Myeloma, Neuroblastoma

Glioblastoma, Melanoma

Frequently asked questions

What is the difference between Evomela and Temodar?

Evomela contains Melphalan Hydrochloride, while Temodar contains Temozolomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.